HRT Clinic Startup Guide

How to Start a
Hormone Replacement Clinic

A startup guide for building a clinically governed HRT practice around appropriate evaluation, pharmacy and lab diligence, patient education, and compliant operations.

What this page coversStarting an HRT clinic requires a physician-led clinical model, a compliant entity structure, licensed clinicians, individualized protocols, lab monitoring, HIPAA-ready technology, pharmacy diligence, and careful marketing. BHRT and pellet services add consent, procedure, and compounding considerations; testosterone requires separate controlled-substance analysis.
Who this is for: Clinicians, clinic owners, healthcare entrepreneurs, and wellness practices building a hormone replacement, menopause, or endocrine-focused service line.
Disclaimer: This guide is educational only and is not medical, legal, pharmacy, or billing advice. Hormone therapy, compounding, telehealth, ownership, and controlled-substance rules vary by state. Obtain current advice from healthcare counsel and qualified clinical leadership.

What Is an HRT Clinic?

Quick answer: An HRT clinic evaluates and manages hormone-related symptoms and conditions through clinician-directed assessment, treatment, monitoring, and referral.

Hormone replacement therapy clinics may serve women, men, or both through menopause care, estrogen and progesterone therapy, testosterone evaluation, DHEA, thyroid-related assessment, sexual health, and metabolic support. The safest model is not a product-dispensing operation. It is a medical practice that evaluates history, contraindications, symptoms, labs when indicated, alternatives, and ongoing response.

The service menu should match clinician competence and the clinic's ability to monitor, manage complications, and refer. Distinguish treatment of diagnosed conditions from broad anti-aging promises. Clear scope protects patients, supports documentation, and makes marketing more accurate.

BHRTMenopauseHormone MonitoringEndocrine Care

Business Entity, MSO, and CPOM

Quick answer: In CPOM states, a physician-owned PC or PLLC commonly provides clinical care while an MSO provides non-clinical support.

Corporate practice of medicine rules can limit non-physician ownership and control of a clinical practice. A compliant structure may use a physician-owned professional corporation or PLLC for professional services and a management services organization for non-clinical operations. The correct arrangement depends on state law and should be designed by healthcare counsel.

Clinical authority belongs with licensed clinicians. The business team can support operations, marketing, billing, technology, and administration, but it should not decide who receives hormones, set dose criteria, override a referral, or pressure clinicians to retain patients. Management and medical-director agreements should document that separation and match the way the clinic actually operates.

Clinical independence: Membership revenue, pharmacy economics, and procedure volume cannot replace individualized medical judgment.

Medical Director and Provider Oversight

Quick answer: The medical director should actively approve protocols, review quality, manage exceptions, and oversee required collaboration or supervision.

The medical director is responsible for more than lending a credential. Active duties commonly include protocol ownership, chart review, lab and adverse-event review, clinician onboarding, referral criteria, informed-consent standards, and response to quality trends. The agreement should state review cadence, decision rights, availability, and escalation responsibilities.

NP and PA practice authority differs by state, as do supervision and collaboration requirements. Telehealth adds patient-location licensure requirements. For testosterone or other controlled substances, every authorized prescriber must separately meet applicable DEA, state registration, and prescribing requirements. Build an auditable credentialing process before any clinician starts seeing patients.

  • Define protocol approval, chart review, exception handling, and adverse-event escalation.
  • Verify state scope, collaboration, licensure, malpractice, and controlled-substance authority.
  • Use regular medical-director quality meetings and document findings.
  • Maintain referral networks for endocrinology, gynecology, urology, primary care, and urgent care.

Schedule a Healthcare Strategy Session

Get Started

Licensing, Credentialing, and Compliance

Quick answer: Launch readiness includes provider licenses, payer enrollment if billing insurance, CAQH, PECOS, HIPAA, OSHA, and DEA controls where applicable.

Verify professional licenses, entity registrations, telehealth authority, malpractice coverage, and any state facility or laboratory obligations. If the clinic bills Medicare, Medicaid, or commercial insurance, complete enrollment and maintain CAQH profiles, PECOS for eligible ordering and referring functions, credentialing files, and revalidation calendars.

HIPAA requires a privacy and security program with business associate agreements, access controls, secure communications, training, breach response, and vendor diligence. OSHA procedures cover bloodborne pathogens, sharps, and employee safety. If the clinic performs qualifying in-office tests, determine the proper CLIA certification. Testosterone and other controlled substances require additional DEA and state-specific workflows where applicable.

HIPAAOSHADEACLIA

BHRT, FDA-Approved Products, and 503A Pharmacies

Quick answer: BHRT can involve FDA-approved products or patient-specific compounded preparations, but their regulatory pathways and patient communications differ.

Bioidentical hormone replacement therapy may describe hormones that are chemically identical to hormones produced by the body. Some are available in FDA-approved products, while others may be prepared for individual patients by a properly licensed 503A compounding pharmacy. The clinic should not imply that compounded medications are FDA-approved or that all products are interchangeable.

Pharmacy diligence should confirm licensure for the patient's state, quality processes, complaint handling, patient-specific prescription requirements, shipping capability, and, where relevant, sterile compounding practices. Keep a pharmacy credentialing file and an escalation process for delivery issues, adverse events, product concerns, and recalls. Prescribing rationale and informed consent should be documented in the clinical record.

  • Verify pharmacy licensure for every patient state and patient-specific prescription capability.
  • Explain the difference between FDA-approved and compounded products accurately.
  • Document clinical rationale, consent, monitoring, and pharmacy communication.
  • Review complaints, fulfillment exceptions, and recalls with clinical leadership.

Pellet Therapy Procedures

Quick answer: Pellet therapy requires trained clinicians, aseptic technique, consent, procedure documentation, follow-up, and a plan for complications.

Pellet therapy can be a long-acting delivery option for selected patients, but it is a procedure, not a retail add-on. The clinic needs written candidacy criteria, training verification, equipment and supply controls, sterile or aseptic workflow as appropriate, procedure documentation, aftercare instructions, follow-up, and escalation for infection, bleeding, extrusion, or other complications.

The medical director should determine which clinicians may perform procedures and how outcomes are reviewed. Consent should describe material risks, alternatives, realistic expectations, monitoring, and what happens if symptoms or labs change before a pellet cycle ends. Do not use volume targets to influence a procedure recommendation.

Procedure elementRequired operational focus
EligibilityIndividualized assessment, contraindication review, and clinical rationale
TechniqueTraining, aseptic process, supplies, and documented procedure note
ConsentRisks, alternatives, aftercare, monitoring, and patient questions
Follow-upSymptom review, labs when indicated, complication response, and referral

Need a Medical Director?

Get Started

Labs, Protocols, and Telehealth

Quick answer: Protocols should define which hormone, metabolic, CBC, thyroid, and safety labs are appropriate, how results are reviewed, and when telehealth is suitable.

HRT protocols should specify an individualized evaluation process rather than a fixed prescription pathway. Depending on the service and patient, clinicians may consider relevant hormone panels, metabolic testing, CBC, thyroid studies, medication history, symptoms, contraindications, and other safety factors. The protocol should set review responsibility, monitoring timing, dose-change rules, and referral thresholds.

Telehealth can support access for many HRT services when clinicians are licensed where the patient is located and comply with consent, prescribing, examination, documentation, and privacy rules. Testosterone is a controlled substance and must be reviewed under current DEA, Ryan Haight, and state requirements separately. Capture patient identity, location, consent, history, findings, clinical rationale, and follow-up plan in the EMR.

Protocol design: Standardization should support clinical judgment, not replace it. A clinician must be able to pause, change, or decline treatment when the record calls for it.

Technology, Staffing, and Partnerships

Quick answer: A reliable HRT operation connects HIPAA-compliant documentation, telehealth, e-prescribing, labs, pharmacy workflows, payments, and trained clinical support.

The core stack may include a HIPAA-compliant EMR, secure telehealth, e-prescribing, online intake, consent, laboratory interfaces, patient messaging, scheduling, payments, and reporting. Evaluate vendors for business associate agreements, security controls, audit logs, data portability, integration reliability, and patient experience.

Staffing often includes a medical director, treating clinicians, medical assistant or nurse support, patient coordinator, billing support, and operations leadership. Assign clear ownership for lab follow-up, refill routing, prior authorization, pharmacy exceptions, procedure supplies, and urgent escalation. Credential labs and pharmacies before marketing services that depend on them.

EMRTelehealthLab InterfaceE-Prescribing

Startup Costs, Cash Pay, and Revenue Cycle

Quick answer: A viable HRT model budgets for legal and clinical infrastructure, then uses transparent cash-pay or payer-billing workflows with disciplined documentation.

A telehealth-first or lean office HRT clinic may need approximately $50,000 to $200,000 for formation, medical leadership, licenses, technology, insurance, staffing, labs, pharmacy setup, compliance, and marketing. A physical practice with procedures, inventory controls, and buildout may require $150,000 to $400,000 or more. Build working-capital reserves rather than assuming immediate membership volume.

Many clinics use cash-pay consultations, memberships, laboratory, medication, or procedure fees. Others bill eligible services to insurance. If billing insurance, build eligibility, coding, prior authorization, claims, denial, and payment-posting workflows. If using memberships, state clearly what is and is not included and avoid presenting the arrangement as insurance.

  • Model legal, compliance, medical-director, quality-review, and technology costs as recurring expenses.
  • Use patient financial agreements for memberships, labs, medications, and procedures.
  • Audit charge capture, coding, medical necessity, denials, and refunds.
  • Track acquisition cost, conversion, churn, clinical capacity, and monitoring completion.

Starting a New Clinic?

Get Started

Marketing, Risk, and Quality Management

Quick answer: Education-led marketing and a documented quality program reduce risk from misleading claims, weak documentation, and unsafe care patterns.

HRT marketing should explain evaluation, symptoms, treatment options, monitoring, and appropriate expectations without promising energy, weight loss, sexual outcomes, rejuvenation, or disease treatment. Paid platforms may restrict prescription-related advertising, and FTC, FDA, state board, and consumer-protection rules can apply. Route ads, landing pages, call scripts, testimonials, and influencer content through review.

Risk management combines malpractice coverage, privacy controls, informed consent, chart audits, lab follow-up, pharmacy oversight, incident review, staff training, and medical-director authority to change workflows. Review patient complaints, refill patterns, adverse events, incomplete labs, and marketing performance for signals that the system needs correction. Growth should follow quality infrastructure.

  • Substantiate claims and avoid guarantees, pressure tactics, and misleading before-and-after framing.
  • Audit charts for history, rationale, consent, labs, dose changes, and follow-up.
  • Review pharmacy, procedure, privacy, and complaint exceptions on a defined cadence.
  • Give medical leadership authority to pause unsafe or noncompliant workflows.

Build the infrastructure behind your clinic.

AJ Pakpour advises physicians, NPs, PAs, clinic owners, and healthcare entrepreneurs on compliance, operations, and growth.

Frequently Asked Questions

What is the difference between FDA-approved and compounded hormones?

FDA-approved products have undergone FDA review for the approved indication, while patient-specific compounded preparations are prepared by licensed compounding pharmacies under a different regulatory pathway. They should not be described as interchangeable without clinician evaluation.

Can an HRT clinic offer pellet therapy?

A clinic may offer pellet procedures when clinicians are trained, licensed, insured, and operating under physician-approved protocols with consent, aseptic technique, follow-up, and complication escalation.

Do HRT clinics need a medical director?

Requirements depend on state law, ownership, clinician mix, and scope. Active physician leadership is important for protocols, supervision or collaboration where required, lab review, quality oversight, and clinical escalation.

Can an HRT clinic operate by telehealth?

Many non-controlled hormone services can be delivered through telehealth when state licensure, patient-location, consent, prescribing, examination, and documentation requirements are met. Controlled substances such as testosterone require separate, current legal analysis.

What labs should an HRT clinic monitor?

The appropriate workup is individualized, but protocols often address relevant hormone panels, metabolic testing, CBC, thyroid testing when indicated, medication risks, symptoms, and follow-up timing. The treating clinician determines testing and interpretation.

Can HRT clinics use a cash-pay model?

Yes. Many use consultation, membership, lab, medication, and procedure fees. Terms should clearly explain inclusions, exclusions, refunds, cancellation, and that clinical decisions are independent of recurring revenue.

How much does it cost to start an HRT clinic?

A telehealth or lean office model may require roughly $50,000 to $200,000, while a clinic with procedures, staff, and buildout can require $150,000 to $400,000 or more. Costs vary by services, market, and state.

What marketing claims are risky for HRT clinics?

Claims that guarantee rejuvenation, weight loss, libido, disease treatment, or outcomes can create FTC, FDA, board, platform, and consumer-protection risk. Claims should be evidence-based, reviewed, and never substitute for individualized care.

Recommended Professional References

The following authoritative resources are recommended for healthcare professionals, clinic owners, compliance officers, and entrepreneurs working in this area. Links open official external websites.

The Menopause Society

Professional organization offering evidence-based menopause education and clinical resources.

Menopause careFree + Paid

Best for: Menopause-focused HRT service lines

Endocrine Society

Leading endocrine professional society with clinical guidance and educational resources.

Endocrine guidanceFree + Paid

Best for: Hormone assessment and monitoring

U.S. Food and Drug Administration: Compounding

FDA resource explaining human drug compounding and its regulatory framework.

Compounding regulationFree

Best for: BHRT and pharmacy due diligence

Pharmacy Compounding Accreditation Board

Accreditation program for compounding pharmacies administered by the Accreditation Commission for Health Care.

Pharmacy accreditationFree + Paid

Best for: Assessing compounding pharmacy quality programs

U.S. Pharmacopeia

Independent standards-setting organization with compounding quality and safety resources.

Compounding standardsFree + Paid

Best for: Sterile and nonsterile compounding diligence

American College of Obstetricians and Gynecologists

Professional organization with women’s health clinical guidance and education.

Clinical guidanceFree + Paid

Best for: Women’s hormone-care protocols and referrals

American Association of Clinical Endocrinology

Professional endocrine organization offering clinical resources and education.

Endocrine careFree + Paid

Best for: Endocrine-focused clinician education

Federation of State Medical Boards

National organization supporting state medical boards and regulatory resources.

Medical regulationFree

Best for: Licensure and state-board research

Book a Healthcare Strategy Session Medical Director Services